Contact:
sales@biotechnologyforums.com to feature here

Thread Rating:
  • 0 Vote(s) - 0 Average
  • 1
  • 2
  • 3
  • 4
  • 5
ROCHE HOLDING AG, Latest News & Vacancies
#3
Roche is a research – based healthcare firm aimed at developing medications and medical devices for early detection and initiation of treatment of several disease conditions. Developed in the year 1986 by Fritz Hoffman – La Roche, the firm was the first to recognize and put into practice the fact that development of standardized medications is extremely beneficial in treating disease conditions. The firm is focused on delivering the best therapies and medical diagnostic tools for oncology, personalized healthcare, virology, rheumatoid arthritis and transplantation.

Roche is traded as ROG and has its shares listed in the SIX Swiss Exchange. It has its headquarters in Basel and its business spread across several countries overseas.

Popular biotech products
Roche’s major focus is on developing products that would make a significant impact on the existing solutions for treating and diagnosing disease conditions. The firm manufactures drugs for treating cancer, infectious diseases, disorders of the central nervous system, inflammatory and metabolic diseases. The following is a list enumerating some of the major products of Roche.
• Actemra
• Anaprox
• Avastin
• Bactrim
• Bondronat
• Bonviva
• CellCept
• Dilatrend
• Dormicum
• Fuzeon
• Herceptin
• Invirase
• Kytril
• Lariam
• Lucentis
• Mabthera
• Madopar
• Mircera
• Pegasys
• RoActemra
• Rocaltrol
• Rocephin
• Roferon-A
• Tarceva

In addition to these, Roche has developed an exhaustive list of pharmaceutical drugs. Apart from drugs, the firm also has hands on expertise in manufacturing diagnostic products and instruments and reagent kits that would be of help in research of varied products.

Latest discoveries
Roche is constantly striving hard to carry out strong research to develop new and innovative products for saving patient’s lives. There are several products that have been recently discovered by this firm. Some of them have been listed below.
• Perjeta and Kadcyla for treatment of advanced HER2 positive gastric cancer.
• Erivedge indicated in patients with operable basal cell carcinoma.
• Zelboraf for patients with papillary thyroid cancer, BRAF mutation positive.
• Tarceva for adjuvant non – small cell lung cancer.
• Actemra for rheumatoid arthritis and systemic sclerosis.
• Xolair for chronic idiopathic urticaria.
• Lucentis for age related macular degeneration.

Recent company takeovers
Roche values mergers and collaborations and understands the importance of the same. The firm believes that along with other like minded firms it can certainly make a positive impact in the lives of patient fighting severe disease conditions. The firm has partnered with several other firms such as Genentech, Ventana, Tucson and Chugai pharmaceuticals for expanding their areas of research as well developing and manufacturing innovative therapies for fighting deadly diseases like cancer.

Recent corporate news
During the fiscal year 2010, the company’s revenues were CHF 47.49 billion.

Work culture
The work culture at Roche is very dynamic and mission driven. With a work force of about 82, 000 the firm is directed towards delivering the best pharmaceutical products and medical devices to the world at large. In other words, they are committed towards building a “better tomorrow”.

Interesting events
Roche is always in the front to deliver the best therapeutic products to the world. The year 2013 has indeed been an eventful year for the firm. Below is a list of some of the interesting news for the current year:
• The firm has developed a new time saving formula of Herceptin that has been approved in Europe for treating HER2 positive breast cancer.
• Roche along with Medicines Patent Pool signed an agreement to increase the access to medications indicated for treatment of HIV patients.
• The media has also been talking about Roche’s obinutuzumab drug that has proved to delay the progression of blood cancer as against the drug rituxan.
• The firm in this year also launched the new tool named ProGPR test for prompt and precise diagnosis of lung cancer.
• The firm received EU approval for the drug Erivedge that is indicated for treatment of basal cell carcinoma.

Recent job openings

There are varied career opportunities at Roche. Be it in the field of marketing, development or research, the firm has many exciting job opportunities for young and experienced individuals. Interested candidates can search the job portal and apply for the type of job that suits them. The following is the list of recent job openings at Roche.
Division Sales Manager: Such individuals would be responsible for hiring, developing and managing team work. They are also responsible for accomplishing the set target and goals in time. For applying for this position, the candidates need to be a graduate or MBA and also have 5 years of work experience. They also need to have a minimum of 2 years of experience in pharmaceutical, biotechnological or therapeutic area.
Clinical specialist: The individuals in this position are responsible for maintaining relationships with physicians and other customers. They need to posses strong communication skills; both written as well as verbal. The candidates need to have a minimum of 2 years of work experience and should at least have a graduate degree. Having previous experience in sales and pharmaceutical industry is an added plus.
Regulatory affairs manager: Such individuals are responsible for maintaining product technical files and also are required to manage the submission activities. They also need to posses current knowledge in applicable regulatory requirements and would also be required to provide support to project teams. Candidates who wish to apply for this position need to be a graduate in engineering or related technical field and should have a minimum of 5 years of experience in development, clinical affairs, medical device, and IVD device.
Associate medical director: In this position, the medical director would be required to report to the director of US drug safety and would be an important member of USDS leadership team. This is so far a new position that has been created in the department and the selected individual should be highly qualified with at least 3 years of experience in drug safety. The individual should also hold an MD or any other equivalent medical degree.
Interested candidates can apply online and wait for the recruitment procedure.
Like Post Reply
  


Messages In This Thread
RE: ROCHE HOLDING AG, Latest News & Job Vacancies - by Jessica - 09-08-2013, 05:40 PM
Possibly Related Threads…
Thread
Author
  /  
Last Post
Replies: 3
Views: 26,534
02-18-2017, 05:29 PM
Last PostAbdul
Replies: 0
Views: 8,896
03-31-2016, 09:06 PM
Last PostHEL Group
Replies: 0
Views: 16,349
07-25-2015, 04:16 AM
Last Postgmshim
Replies: 1
Views: 19,460
03-26-2015, 04:12 PM
Last Postjuston33



Users browsing this thread:
1 Guest(s)

ROCHE HOLDING AG, Latest News & Vacancies00